<< Kaiser Permanente hosts in-person and virtual Residency Program Open House | New report on the global biomarker tools and services market >>
Read in | English | Español | Français | Deutsch | Português | Italiano | 日本語 | 한국어 | 简体中文 | 繁體中文 | Nederlands | Русский

Reportlinker adds new report on enymes market

Published on September 11, 2009 at 6:53 AM · No Comments

Reportlinker.com announces that a new market research report is available in its catalogue.

Reportlinker Adds World Enzymes Market

http://www.reportlinker.com/p0148002/Reportlinker-Adds-World-Enzymes-Market.html

Enzyme demand worldwide to reach $7 billion in 2013

The world market for enzymes will recover from a difficult 2009 to reach $7 billion in 2013. Continued strong demand for specialty enzymes, as well as above average growth in the animal feed and ethanol production markets, will drive advances. Reflecting the above-average growth in specialty enzymes, nucleases and polymerases, along with various other enzyme types, will outpace the more industrially concentrated lipases, carbohydrases and proteases. From a regional perspective, the developed economies of North America and Western Europe will achieve healthy gains, while the fastest growth will continue to come from the more rapidly developing economies of the Asia/Pacific and Africa/ Mideast regions, as well as Latin America and Eastern Europe. World enzyme demand grew at a nearly double-digit pace from 2003 to 2008, helped in large part by the rapid increase in world energy prices (which made enzyme-related processes and products more cost effective, and facilitated the legislation of a rapid expansion of the fuel ethanol market, particularly in the United States) and the successful launch of several enzyme-containing pharmaceuticals. With the world in a global economic downturn in 2009, however, the market for enzymes has become much more challenging, and growth will moderate significantly going forward.

Pharmaceutical, biocatalyst enzymes to lead growth

Through 2013 world enzyme demand will average annual gains of 6.3 percent per year, led by pharmaceutical and biocatalyst enzymes, both of which will be less susceptible to the effects of lowered economic activity. Diagnostics enzyme demand will also fair well due to expanded access to medical care in developing countries, and the drive to achieve nearly universal health care in the United States. With pharmaceutical companies having difficulty bringing new small-molecule drugs to market, biotechnology will continue to gain in importance, helping to sustain demand for research and biotechnology enzymes.

Animal feed, ethanol markets fastest growing

Comments
The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News-Medical.Net.



  Country flag

biuquote
  • Comment
  • Preview
Loading